Aquestive Interest Income from 2010 to 2025

AQST Stock  USD 2.72  0.03  1.09%   
Aquestive Therapeutics Interest Income yearly trend continues to be comparatively stable with very little volatility. Interest Income is likely to outpace its year average in 2025. Interest Income is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. View All Fundamentals
 
Interest Income  
First Reported
2019-03-31
Previous Quarter
1.4 M
Current Value
979 K
Quarterly Volatility
3.2 M
 
Covid
Check Aquestive Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aquestive Therapeutics' main balance sheet or income statement drivers, such as Interest Expense of 9.5 M, Selling General Administrative of 43.5 M or Total Revenue of 48.2 M, as well as many indicators such as Price To Sales Ratio of 3.76, Dividend Yield of 0.0 or Days Sales Outstanding of 47.57. Aquestive financial statements analysis is a perfect complement when working with Aquestive Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Aquestive Therapeutics Correlation against competitors.
For more information on how to buy Aquestive Stock please use our How to Invest in Aquestive Therapeutics guide.

Latest Aquestive Therapeutics' Interest Income Growth Pattern

Below is the plot of the Interest Income of Aquestive Therapeutics over the last few years. It is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. Aquestive Therapeutics' Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aquestive Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Interest Income10 Years Trend
Slightly volatile
   Interest Income   
636.132.423.99.016.318.819.7-79%220%-77%16386%15%5%100%
       Timeline  

Aquestive Interest Income Regression Statistics

Arithmetic Mean6,715,422
Geometric Mean2,674,881
Coefficient Of Variation98.01
Mean Deviation4,728,942
Median6,893,000
Standard Deviation6,582,014
Sample Variance43.3T
Range19.6M
R-Value0.40
Mean Square Error38.9T
R-Squared0.16
Significance0.12
Slope554,613
Total Sum of Squares649.8T

Aquestive Interest Income History

202519.7 M
202418.8 M
202316.3 M
202299 K
2021423 K
2020132 K
2019636 K

Other Fundumenentals of Aquestive Therapeutics

Aquestive Therapeutics Interest Income component correlations

-0.280.23-0.420.870.590.280.59-0.520.99-0.47-0.32-0.83-0.380.16-0.81-0.840.67-0.190.7-0.190.740.4-0.19
-0.280.60.98-0.040.060.05-0.890.42-0.210.37-0.380.620.65-0.740.070.44-0.80.440.40.440.23-0.870.44
0.230.60.570.27-0.04-0.29-0.4-0.440.33-0.35-0.03-0.16-0.17-0.54-0.47-0.29-0.120.220.790.220.66-0.380.22
-0.420.980.57-0.15-0.1-0.1-0.930.44-0.350.38-0.250.70.63-0.710.170.51-0.850.440.280.440.07-0.880.44
0.87-0.040.27-0.150.520.110.34-0.280.88-0.34-0.29-0.57-0.080.14-0.79-0.70.39-0.10.68-0.10.640.17-0.1
0.590.06-0.04-0.10.520.730.120.160.590.07-0.8-0.210.17-0.2-0.13-0.160.16-0.010.5-0.010.49-0.15-0.01
0.280.05-0.29-0.10.110.730.090.290.240.44-0.680.020.35-0.210.10.06-0.050.050.130.050.28-0.040.05
0.59-0.89-0.4-0.930.340.120.09-0.50.52-0.440.24-0.77-0.650.72-0.34-0.620.93-0.26-0.07-0.260.070.9-0.26
-0.520.42-0.440.44-0.280.160.29-0.5-0.550.82-0.380.840.89-0.220.650.81-0.710.37-0.370.37-0.55-0.590.37
0.99-0.210.33-0.350.880.590.240.52-0.55-0.5-0.3-0.82-0.390.11-0.81-0.840.64-0.160.76-0.160.80.34-0.16
-0.470.37-0.350.38-0.340.070.44-0.440.82-0.5-0.310.680.82-0.40.580.59-0.720.33-0.310.33-0.48-0.50.33
-0.32-0.38-0.03-0.25-0.29-0.8-0.680.24-0.38-0.3-0.31-0.12-0.430.570.05-0.080.23-0.14-0.43-0.14-0.350.51-0.14
-0.830.62-0.160.7-0.57-0.210.02-0.770.84-0.820.68-0.120.79-0.340.70.93-0.890.35-0.430.35-0.54-0.680.35
-0.380.65-0.170.63-0.080.170.35-0.650.89-0.390.82-0.430.79-0.370.360.64-0.830.34-0.120.34-0.26-0.660.34
0.16-0.74-0.54-0.710.14-0.2-0.210.72-0.220.11-0.40.57-0.34-0.37-0.13-0.230.63-0.37-0.44-0.37-0.240.84-0.37
-0.810.07-0.470.17-0.79-0.130.1-0.340.65-0.810.580.050.70.36-0.130.84-0.470.26-0.640.26-0.74-0.340.26
-0.840.44-0.290.51-0.7-0.160.06-0.620.81-0.840.59-0.080.930.64-0.230.84-0.710.4-0.520.4-0.59-0.570.4
0.67-0.8-0.12-0.850.390.16-0.050.93-0.710.64-0.720.23-0.89-0.830.63-0.47-0.71-0.30.15-0.30.30.84-0.3
-0.190.440.220.44-0.1-0.010.05-0.260.37-0.160.33-0.140.350.34-0.370.260.4-0.30.211.0-0.03-0.451.0
0.70.40.790.280.680.50.13-0.07-0.370.76-0.31-0.43-0.43-0.12-0.44-0.64-0.520.150.210.210.87-0.250.21
-0.190.440.220.44-0.1-0.010.05-0.260.37-0.160.33-0.140.350.34-0.370.260.4-0.31.00.21-0.03-0.451.0
0.740.230.660.070.640.490.280.07-0.550.8-0.48-0.35-0.54-0.26-0.24-0.74-0.590.3-0.030.87-0.030.03-0.03
0.4-0.87-0.38-0.880.17-0.15-0.040.9-0.590.34-0.50.51-0.68-0.660.84-0.34-0.570.84-0.45-0.25-0.450.03-0.45
-0.190.440.220.44-0.1-0.010.05-0.260.37-0.160.33-0.140.350.34-0.370.260.4-0.31.00.211.0-0.03-0.45
Click cells to compare fundamentals

About Aquestive Therapeutics Financial Statements

Aquestive Therapeutics shareholders use historical fundamental indicators, such as Interest Income, to determine how well the company is positioned to perform in the future. Although Aquestive Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Aquestive Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Aquestive Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Interest Income18.8 M19.7 M
Net Interest Income10.2 M10.7 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Aquestive Stock Analysis

When running Aquestive Therapeutics' price analysis, check to measure Aquestive Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aquestive Therapeutics is operating at the current time. Most of Aquestive Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aquestive Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aquestive Therapeutics' price. Additionally, you may evaluate how the addition of Aquestive Therapeutics to your portfolios can decrease your overall portfolio volatility.

Trending Assets

LNTH
Lantheus Holdings
91.49  -1.76  -1.89 
ACRX
AcelRx Pharmaceuticals
0.00  0.00  0.00 
MNK
Mallinckrodt Plc
0.00  0.00  0.00 
AMPH
Amphastar P
31.49  0.28  0.90 
LSDI
Lucy Scientific Discovery
0.00  0.00  0.00 
LFCR
Lifecore Biomedical
5.77  -0.2  -3.35 
AGRX
Agile Thrpe
0.00  0.00  0.00 
ALIM
Alimera Sciences
0.00  0.00  0.00 
ORGO
Organogenesis Holdings
3.07  -0.18  -5.54 
ADMP
Adamis Pharma
0.00  0.00  0.00 
DVAX
Dynavax Technologies
13.58  -0.11  -0.8 
SHPH
Shuttle Pharmaceuticals
0.61  0.01  1.67 
ALKS
Alkermes Plc
34.04  -0.76  -2.18 
EVOK
Evoke Pharma
4.88  0.05  1.04 
GHSI
Guardion Health Sciences
0.00  0.00  0.00 
EGRX
Eagle Pharmaceuticals
0.00  0.00  0.00 
IRWD
Ironwood Pharmaceuticals
1.62  -0.09  -5.26 
ANIP
ANI Pharmaceuticals
54.58  -0.43  -0.78 
News Freq…Investor S…